EDGAR Filing Documents for 0000897069-02-000253

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0000897069-02-000253

Filing Date

2002-04-01

Accepted

2002-04-01 00:00:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-3 REGISTRATION STATEMENT	slp265.txt	F-3	73186
3	STOCK PURCHASE WARRANT	slp265a.txt	EX-2.0	34030
4	OPINION OF JACK GEMMELL	slp265b.txt	EX-5.0	8095
5	CONSENT OF KPMG LLP	slp265c.txt	EX-23.1	1065
	Complete submission text file	0000897069-02-000253.txt		118187

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-85266 | Film No.: 02595919
SIC: 2835 In Vitro & In Vivo Diagnostic Substances